BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26922344)

  • 1. Development and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides.
    Kauhanen D; Sysi-Aho M; Koistinen KM; Laaksonen R; Sinisalo J; Ekroos K
    Anal Bioanal Chem; 2016 May; 408(13):3475-83. PubMed ID: 26922344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS.
    Ge K; Zheng D; Wang J; Jia W; Zhao A
    Anal Biochem; 2023 Jan; 661():114982. PubMed ID: 36375519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a RPLC-MS/MS method for the quantification of ceramides in human serum.
    Begou OA; Deda O; Karagiannidis E; Sianos G; Theodoridis G; Gika HG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122734. PubMed ID: 33991953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening assay for the quantification of Cer d18:1/16:0, d18:1/24:0, d18:1/24:1, d18:1/18:0, d18:1/14:0, d18:1/20:0, and d18:1/22:0 in HepG2 cells using RapidFire mass spectrometry.
    Dittakavi S; Mahadevan L; Chandrashekar DV; Bhamidipati RK; Suresh J; Dhakshinamoorthy S; Li Z; Baerenz F; Tennagels N; Mullangi R
    Biomed Chromatogr; 2020 May; 34(5):e4790. PubMed ID: 31883352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide ratios are affected by cigarette smoke but not heat-not-burn or e-vapor aerosols across four independent mouse studies.
    Lavrynenko O; Titz B; Dijon S; Santos DD; Nury C; Schneider T; Guedj E; Szostak J; Kondylis A; Phillips B; Ekroos K; Martin F; Peitsch MC; Hoeng J; Ivanov NV
    Life Sci; 2020 Dec; 263():118753. PubMed ID: 33189821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of α-hydroxy ceramides in mice serum by LC-MS/MS: Application to sepsis study.
    Chao Y; Chen X; Shi X; Li N; Gao S; Yang J; Dong X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123764. PubMed ID: 37267800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma.
    Jiang H; Hsu FF; Farmer MS; Peterson LR; Schaffer JE; Ory DS; Jiang X
    Anal Bioanal Chem; 2013 Sep; 405(23):7357-65. PubMed ID: 23857140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between ceramides and coronary artery stenosis in patients with coronary artery disease.
    Tu C; Xie L; Wang Z; Zhang L; Wu H; Ni W; Li C; Li L; Zeng Y
    Lipids Health Dis; 2020 Jun; 19(1):151. PubMed ID: 32586390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Canali G; Byrne CD; Gori S; Barbieri E; Targher G
    Metabolism; 2018 Aug; 85():305-312. PubMed ID: 29777715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma ceramides are associated with coronary atherosclerotic burden in patients with ST-segment elevation myocardial infarction.
    Pan W; Li L; Sun M; Wang C; Fang S; Yu B
    Int J Cardiol; 2020 Dec; 320():155-160. PubMed ID: 32800902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of urinary sphingolipids using liquid chromatography-tandem mass spectrometry in diabetic nephropathy.
    Morita Y; Kurano M; Sakai E; Nishikawa T; Nishikawa M; Sawabe M; Aoki J; Yatomi Y
    J Diabetes Investig; 2020 Mar; 11(2):441-449. PubMed ID: 31580528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
    Mantovani A; Altomari A; Lunardi G; Bonapace S; Lippi G; Bonnet F; Targher G
    Diabetes Metab; 2020 Sep; 46(4):326-330. PubMed ID: 31185304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.
    Laaksonen R; Ekroos K; Sysi-Aho M; Hilvo M; Vihervaara T; Kauhanen D; Suoniemi M; Hurme R; März W; Scharnagl H; Stojakovic T; Vlachopoulou E; Lokki ML; Nieminen MS; Klingenberg R; Matter CM; Hornemann T; Jüni P; Rodondi N; Räber L; Windecker S; Gencer B; Pedersen ER; Tell GS; Nygård O; Mach F; Sinisalo J; Lüscher TF
    Eur Heart J; 2016 Jul; 37(25):1967-76. PubMed ID: 27125947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes.
    Mantovani A; Csermely A; Sani E; Beatrice G; Petracca G; Lunardi G; Bonapace S; Lippi G; Targher G
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating sphingolipids as biomarkers for the outcomes of acute ischemic stroke patients receiving endovascular treatment.
    Lee TH; Cheng CN; Lee CW; Kuo CH; Tang SC; Jeng JS
    J Formos Med Assoc; 2023 Jan; 122(1):19-28. PubMed ID: 36184387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Gori S; Barbieri E; Verlato G; Laaksonen R; Byrne CD; Targher G
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2854-2861. PubMed ID: 30571175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating ceramide levels and ratios in Emirati youth under 18 years: associations with cardiometabolic risk factors.
    Shalaby YM; Al-Zohily B; Raj A; Yasin J; Al Hamad S; Antoniades C; Akawi N; Aburawi EH
    Lipids Health Dis; 2024 Apr; 23(1):93. PubMed ID: 38561799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.
    Mantovani A; Bonapace S; Lunardi G; Canali G; Dugo C; Vinco G; Calabria S; Barbieri E; Laaksonen R; Bonnet F; Byrne CD; Targher G
    Diabetes Metab; 2020 Apr; 46(2):150-157. PubMed ID: 31386900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-LC-MS/MS for the quantitation of ceramides in mice cerebrospinal fluid using minimal sample volume.
    Thomas D; Eberle M; Schiffmann S; Zhang DD; Geisslinger G; Ferreirós N
    Talanta; 2013 Nov; 116():912-8. PubMed ID: 24148494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of human stratum corneum ceramides by means of normal phase LC/APCI-MS.
    Farwanah H; Wohlrab J; Neubert RH; Raith K
    Anal Bioanal Chem; 2005 Oct; 383(4):632-7. PubMed ID: 16184366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.